Trials / Completed
CompletedNCT00586664
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy and safety study of bepotastine besilate ophthalmic solution in allergic conjunctivitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bepreve (bepotastine besilate ophthalmic solution) 1.5% | sterile ophthalmic solution |
| DRUG | placebo comparator | sterile ophthalmic solution |
| DRUG | Bepotastine Besilate Ophthalmic Solution 1.0% | sterile ophthalmic solution |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-01-04
- Last updated
- 2013-02-08
- Results posted
- 2012-03-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00586664. Inclusion in this directory is not an endorsement.